Literature DB >> 10450875

Developmental expression and localization of glycogen synthase kinase-3beta in rat brain.

K Leroy1, J P Brion.   

Abstract

Glycogen synthase kinase (GSK)-3beta is a protein kinase in the wingless/wnt pathway and as such is involved in the regulation of growth and development of the neural tissue in Drosophila and in vertebrates. This enzyme is also abundantly expressed in the mammal adult brain, where it might play a role in the regulation of several substrates. The expression and the neuroanatomical distribution of GSK-3beta immunoreactivity in the rat brain from embryonic up to adult stages has been studied. GSK-3beta was expressed in the developing brain with the highest expression observed from 18 days of embryonic life up to 10 days of postnatal life. Its expression decreased thereafter and was lowest in the adult. GSK-3beta was strongly expressed in developing neurons but only weakly expressed in layers containing neuroblasts. In the adult and during development, GSK-3beta was detected in the pericarya and proximal part of dendrites. In the embryo, an intense GSK-3beta immunoreactivity was also observed in axonal tracts. This axonal immunoreactivity had markedly decreased by 10 days of postnatal life and was absent at 20 days of postnatal life and in the adult. No GSK-3beta immunoreactivity was detected in astrocytes. The GSK-3beta immunoreactivity was found in most brain regions, although significant local variations of GSK-3beta expression were observed. The developmental evolution of GSK-3beta compartmentalization in neurons parallels that of phosphorylated tau, a protein considered to be a physiological substrate for the kinase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10450875     DOI: 10.1016/s0891-0618(99)00012-5

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  71 in total

1.  Hydroxysafflor yellow A protects against cerebral ischemia-reperfusion injury by anti-apoptotic effect through PI3K/Akt/GSK3β pathway in rat.

Authors:  Lin Chen; Yanxiao Xiang; Lingjun Kong; Xiumei Zhang; Baozhu Sun; Xinbing Wei; Huiqing Liu
Journal:  Neurochem Res       Date:  2013-08-29       Impact factor: 3.996

2.  Mild hypothermia decreases GSK3beta expression following global cerebral ischemia.

Authors:  Stephen Kelly; Danye Cheng; Gary K Steinberg; Midori A Yenari
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 3.  The role of GSK-3 in synaptic plasticity.

Authors:  S Peineau; C Bradley; C Taghibiglou; A Doherty; Z A Bortolotto; Y T Wang; G L Collingridge
Journal:  Br J Pharmacol       Date:  2008-03       Impact factor: 8.739

4.  GSK3β Hyperactivity during an Early Critical Period Impairs Prefrontal Synaptic Plasticity and Induces Lasting Deficits in Spine Morphology and Working Memory.

Authors:  Bo Xing; Yan-Chun Li; Wen-Jun Gao
Journal:  Neuropsychopharmacology       Date:  2016-06-29       Impact factor: 7.853

5.  Preclinical MRI: Studies of the irradiated brain.

Authors:  Joel R Garbow; Christina I Tsien; Scott C Beeman
Journal:  J Magn Reson       Date:  2018-04-26       Impact factor: 2.229

6.  Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease.

Authors:  J K Morris; H Zhang; A A Gupte; G L Bomhoff; J A Stanford; P C Geiger
Journal:  Brain Res       Date:  2008-09-11       Impact factor: 3.252

7.  GSK-3beta gene expression in human postmortem brain: regional distribution, effects of age and suicide.

Authors:  Ghanshyam N Pandey; Yogesh Dwivedi; Hooriyah S Rizavi; Tara Teppen; Gabor L Gaszner; Rosalinda C Roberts; Robert R Conley
Journal:  Neurochem Res       Date:  2008-06-28       Impact factor: 3.996

8.  Synthesis and Initial in Vivo Studies with [(11)C]SB-216763: The First Radiolabeled Brain Penetrative Inhibitor of GSK-3.

Authors:  Lei Li; Xia Shao; Erin L Cole; Stephan A Ohnmacht; Valentina Ferrari; Young T Hong; David J Williamson; Tim D Fryer; Carole A Quesada; Phillip Sherman; Patrick J Riss; Peter J H Scott; Franklin I Aigbirhio
Journal:  ACS Med Chem Lett       Date:  2015-03-10       Impact factor: 4.345

9.  A novel GSK-3β inhibitor YQ138 prevents neuronal injury induced by glutamate and brain ischemia through activation of the Nrf2 signaling pathway.

Authors:  Tao Pang; Yun-Jie Wang; Yuan-Xue Gao; Yuan Xu; Qiu Li; Yu-Bo Zhou; Lei Xu; Zhang-Jian Huang; Hong Liao; Lu-Yong Zhang; Jian-Rong Gao; Qing Ye; Jia Li
Journal:  Acta Pharmacol Sin       Date:  2016-04-25       Impact factor: 6.150

Review 10.  Deregulation of brain insulin signaling in Alzheimer's disease.

Authors:  Yanxing Chen; Yanqiu Deng; Baorong Zhang; Cheng-Xin Gong
Journal:  Neurosci Bull       Date:  2014-03-20       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.